baber/WOPTO huggingface dataset:
Patent AU-2018254411-A1 (AU)
Title: LNG process for variable pipeline gas composition
Inventor: PRADERIO ATTILIO J
IPC: F25J1/00
Filed: 2018-04-17
Abstract: The invention relates to a system, method and apparatus for processing natural gas in an LNG facility. A natural gas feed is introduced into a heavies removal unit. The heavies removal system includes a heavies removal column and a distillation column. The heavies removal column and the distillation column are connected via a purge/recovery line. One or more components of the natural gas feed is purged from the heavies removal column to the distillation column via the purge/recovery line to obtain a specified concentration or concentration range of heavy components feeding into the distillation column.
Patent AU-2018255314-A1 (AU)
Title: Apparatus and method of aggregating and supplying energy
Inventor: QURESHI WASEEM ASHRAF
IPC: G05F1/70
Filed: 2018-04-18
Abstract: An apparatus and method for aggregating and supplying energy includes a plurality of power modules for inverting a first type of electrical power, which is supplied to the power modules from multiple sources of power, to a second type of electrical power at an output of the power modules for delivery of the inverted power to a storage device for future use, or to an electrical load, or to a regional or central utility grid. A power microcontroller is carried by and incorporated within each of the power modules and each is configured fo controlling the power inversion operations. The power microcontrollers are configured for generating, from each of the plurality of power modules, controlled pulses of charge and discharge for increasing storage capacity of the energy storage device. A control microcontroller is configured for monitoring voltage levels within the at least one energy storage device and for rebalancing voltage within the energy storage device.
Patent AU-2018256610-A1 (AU)
Title: Method for adjusting the temperature of a patient
Inventor: SCOTT DAVID
IPC: A61F7/00
Filed: 2018-11-01
Abstract: C:\Users\ejl\AppData\Local\Temp\inMailX\i\0027\a\U\I\div spec.docx-1/11/2018 A method for adjusting the temperature of a patient, comprising: circulating a primary fluid in a primary fluid circuit; circulating secondary fluid through a heat exchanger in thermal communication with the primary fluid circuit and a secondary heat exchanger in thermal 5 communication with a patient; maintaining a temperature of the primary fluid at a target temperature under a thermal load in the range of between 400 and 550 watts.
Patent AU-2018264044-A1 (AU)
Title: Coupling device
Inventor: HULSEBOS MICHEL
IPC: F16L21/08
Filed: 2018-11-14
Abstract: Coupling device (1) for a pipe (2), comprising a sleeve (13) for receiving the pipe (2) and at least one seal ing member (5) to provide a seal between the sleeve (13) and the pipe (2), a pressure member (6) for applying a pressure to 5 the sleeve (13) and to the pipe (2), and a grip element (4) extending along at least a part of the perimeter of the pipe (2), wherein the grip element (4) is provided with dents (9) pressed out of the plane of the grip element (4) adjacent to slit like openings (8) punched out of the grip element (4), .0 wherein edges (8') of the slit like openings (8) are subjected to a peening operation.
Patent AU-2018264147-A1 (AU)
Title: Improved access control using portable electronic devices
Inventor: TROESCH FLORIAN
IPC: G07C9/00
Filed: 2018-11-16
Abstract: Abstract To control access to a predetermined service or area, a system receives an activation signal indicative of a user's activation of an access code. As a result of receiving the activation signal, the system sends a verification code to a portable electronic device 5 (170) of the user (150). An access terminal (180) receives the verification code. Access to the predetermined service or area is granted if the verification code is received at the access terminal (180) meeting one of several predetermined conditions. One condition requires that the verification code is provided to the access terminal (180) within a limited validity time. RECEIVE ACTIVATION SIGNAL 310 SEND VERIFICATION CODE TO PORTABLE ELECTRONIC 330 RECEIVE VERIFICATION CODE 340 GRANTS ACCESS TO USER IF VERIFICATION CODE MEETS
Patent AU-2018266281-A1 (AU)
Title: Trial liner
Inventor: LANDERS PETER
IPC: A61F2/34
Filed: 2018-04-24
Abstract: A trial liner for fitting in a shell part of an orthopaedic joint prosthesis has a concave inner bearing surface for articulation with a head part, and an opposite outer surface. The liner has first and second portions which are separated by a slot extending between the inner and outer surfaces which has first and second ends. The slot divides the liner into first and second portions which are connected to one another by means of a first hinge at the first end of the slot and a second hinge at the second end of the slot. Each of the first and second portions has a locking feature in the form of a recess or protrusion which can engage a corresponding locking feature on the internal surface of a shell part to lock the liner into the shell part. The hinges allow the first portion of the liner to pivot relative to the second portion between first and second configurations, in which the distance between the first and second portions is less in the second configuration than in the first configuration.
Patent AU-2018277769-A1 (AU)
Title: Delivery systems with telescoping capsules for deploying prosthetic heart valve devices
Inventor: MAUCH KEVIN
IPC: A61F2/24
Filed: 2018-05-30
Abstract: Delivery systems with telescoping capsules for delivering prosthetic heart valve devices and associated methods are disclosed herein. A delivery system configured in accordance with embodiments of the present technology can include, for example, a delivery capsule having a first housing, a second housing slidably disposed within a portion of the first housing, and a prosthetic device constrained within the first and second housings. The delivery capsule can further include first and second chamber defined in part by the first and second housings. During deployment, fluid is delivered to the first chamber to move the first housing distally over the second housing, thereby releasing a portion of the prosthetic device. Subsequently, fluid is delivered to the second chamber such that the first and second housings move together in the distal direction to release a second portion of the prosthetic device.
Patent AU-2018282533-A1 (AU)
Title: Bed seed holder for grow pod
Inventor: MILLAR GARY BRET
IPC: A01G9/029
Filed: 2018-05-25
Abstract: The invention concerns a bed seed holder (230,330,430,530) and an assembly line grow pod (100) incorporating such a bed seed holder (230,330,430,530) for growing plants. The bed seed holder (230,330,430,530) includes a body having an elevation envelope (540), at least one seed receptacle extending into the body, where the seed receptacle is adapted to maintain a fluid within the seed receptacle, and a spigot (336,536) that is adapted to maintain a level of the fluid within the body below the elevation envelope (540).
Patent AU-2018302367-A1 (AU)
Title: Tyrothricin for use in the treatment or prophylaxis of body odour and preparations therefor
Inventor: LEIBBRAND THOMAS
IPC: A41B11/00
Filed: 2018-07-03
Abstract: The invention relates to the therapeutic or non-therapeutic use of tyrothricin for the treatment and/or prophylaxis of body odour in humans, preferably by local (topical) surface application and/or preferably by application to wound-free skin and/or mucosa. A therapeutic, preferably pharmaceutical, or non-therapeutic, preferably cosmetic, composition is described for the treatment and/or prophylaxis of body odour in humans, the composition containing tyrothricin and a keratolytic. A kit, containing tyrothricin and a keratolytic, and a footwear article, which contains tyrothricin, are also described.
Patent AU-2018312349-A1 (AU)
Title: Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
Inventor: FENSTER ERIK
IPC: C07D403/12
Filed: 2018-07-31
Abstract: The invention provides compounds of formula (I) or a pharmaceutically-acceptable salt thereof, wherein the variables are defined in the specification, that are inhibitors of JAK kinases, particularly JAK3. The invention also provides crystalline forms, pharmaceutical compositions comprising such compounds, methods of using such compounds to treat gastrointestinal and other inflammatory diseases, and processes and intermediates useful for preparing such compounds.
Patent AU-2018347773-A1 (AU)
Title: Non-invasive ambulatory monitoring of pulse transit time
Inventor: SPENCER DARREN
IPC: A61B5/0205
Filed: 2018-10-11
Abstract: There is provided an ambulatory system, comprising at least first and second wearable sensors, for determining pulse transit time (PTT) between at least a first and at least a second fixed location within the cardiovascular system of a subject. The system comprises at least a first device, wherein the first device can contact the skin of the subject, the first device being positioned proximate to the first fixed location; and also comprises at least a second device, wherein the second device can contact the skin of the subject, the second device being positioned proximate to the second fixed location. The system further comprises a data collection module that is in communication with the first and second devices. The first device is configured to detect a timing cue within the cardiac cycle of the subject, and the second device is configured to detect a pulse pressure wave passing through the second fixed location. The data collection module collects data relating to the transition of the pulse pressure wave passing through the second fixed location, thereby enabling determination of a pulse transit time (PTT) between the first and second fixed locations.
Patent AU-2018384707-A1 (AU)
Title: Devices and methods for precision dose delivery
Inventor: ULLA SIBGAT
IPC: A61M5/315
Filed: 2018-12-12
Abstract: Disclosed herein are delivery devices for delivering a volume of a drug product, placebo product, or other product including a fluid. The devices may include a barrel having a longitudinal axis, a proximal end region, and a distal end region. The proximal end region may include an opening, and the barrel may be configured to receive a drug therein. A plunger rod may be disposed at least partially inside the barrel and protruding from the opening. The plunger rod may include a rack having a plurality of teeth. The device may further include a pinion having a plurality of teeth configured to engage with the plurality of teeth of the rack, and rotation of the pinion against the rack may move at least a part of the plunger rod along the longitudinal axis of the barrel.
Patent AU-2018394106-A1 (AU)
Title: Processing of histology images with a convolutional neural network to identify tumors
Inventor: GEORGESCU WALTER
IPC: G06K9/20
Filed: 2018-12-21
Abstract: A convolutional neural network CNN is applied to identifying tumors in a histological image. The CNN has one channel assigned to each of a plurality of tissue classes that are to be identified, there being at least one class for each of non-tumorous and tumorous tissue types. Multi-stage convolution is performed on image patches extracted from the histological image followed by multi-stage transpose convolution to recover a layer matched in size to the input image patch. The output image patch thus has a one-to-one pixel-to-pixel correspondence with the input image patch such that each pixel in the output image patch has assigned to it one of the multiple available classes. The output image patches are then assembled into a probability map that can be co-rendered with the histological image either alongside it or over it as an overlay. The probability map can then be stored linked to the histological image.
Patent AU-2018397436-A1 (AU)
Title: Liquid oral formulations for PDE V inhibitors
Inventor: PANDYA JINAL
IPC: A61K31/519
Filed: 2018-12-24
Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
Patent AU-2018403177-A1 (AU)
Title: Data isolation in distributed hash chains
Inventor: GABRIEL MICHAEL R
IPC: H04L29/08
Filed: 2018-09-20
Abstract: Certain aspects of the present disclosure provide techniques for managing data in a plurality of nodes of a distributed system. Embodiments include storing, by a node of the plurality of nodes, sensitive data in a block of a hash chain. Embodiments further include determining, by the node, that the sensitive data should not be distributed to other nodes of the plurality of nodes. Embodiments further include distributing, by the node, a limited version of the block to the other nodes. The limited version of the block may comprise a hash and a pointer to a previous block of the hash chain, and the limited version of the block may not contain the sensitive data.
Patent AU-2018409826-A1 (AU)
Title: Heart valve docking devices and systems
Inventor: PATEL DARSHIN S
IPC: A61F2/24
Filed: 2018-02-23
Abstract: Docking devices for docking a prosthetic valve at a native valve of a heart can include a coiled docking anchor and a retrieval suture. The docking device and retrieval suture can be configured for improved retention and retrieval of the docking device after deployment. The docking devices can have an end portion with a central axis. The retrieval suture can be connected to the end portion such that a line of force applied by applying tension to the retrieval suture is substantially aligned with the central axis.
Patent AU-2019200795-A1 (AU)
Title: A motion device
Inventor: MACLENNAN ROSS STEWART
IPC: G09B9/00
Filed: 2019-02-06
Abstract: Abstract The present invention relates to a motion device, such as a flight simulator, including a frame including a plurality of roller assemblies mounted thereto and an at least partially rounded body supported on the roller assemblies. The roller assemblies are operable to contact an external surface of the body and to allow movement of the body in a pitch direction, a yaw direction and a roll direction relative to the frame. In an embodiment one or more of the roller assemblies are selectively drivable to controllably drive the movement of the body in the pitch direction, the yaw direction and the roll direction relative to the frame. The above mentioned embodiment of the invention is advantageous in that it provides for motion (i.e. rotation) of the body in the pitch, roll and yaw directions to be driven in a controlled fashion, which could include a desired direction such as the pitch, roll or yaw direction, a desired speed of rotation of the body and a desired acceleration of the body.
Patent AU-2019201449-A1 (AU)
Title: Borehole survey instrument and method
Inventor: WALLIS NICHOLAS PETER
IPC: E21B47/02
Filed: 2019-03-01
Abstract: A method for determining an azimuth of a borehole using a borehole survey instrument, the borehole survey instrument comprising a rate sensor having a sensing axis, wherein the sensing axis is perpendicular to a longitudinal axis of the borehole survey instrument, the method comprising determining a first horizontal earth rate component and a fixed bias drift term of the rate sensor by rotating the rate sensor about the longitudinal axis of the borehole survey instrument and collecting data along the sensing axis at at least two different orientations which lie in a plane perpendicular to the longitudinal axis, rotating the rate sensor about a second axis and collecting data along the sensing axis at a further orientation lying outside of the plane perpendicular to the longitudinal axis, determining a second horizontal earth rate component using the previously determined fixed bias drift term and the data collected at the further orientation, calculating the azimuth using the first horizontal earth rate component and the second horizontal earth rate component. 11130850 _1 (GHMatters) P110785.AU N Er1 I ErxcosP Er4 W 270 go E Er x sinW 180 Er3 S Er2 Fig. 1 rotation axis rotating reference frame F&h Earth Equator ------ ---- ------ inertial reference frame Fig. 2
Patent AU-2019201971-A1 (AU)
Title: Platform agnostic modular framework
Inventor: JADHAV AJAY
IPC: G06F13/00
Filed: 2019-03-21
Abstract: Data systems and processes are disclosed that are capable of providing a modular framework for accessing and manipulating information across multiple device platforms synchronously. The system includes a server-side module repository including at least one module, a subscription service configured to be implemented through a client graphical user interface (GUI) of the multiple device platforms that provides access to interact and navigate the at least one module, and an architecture that allows the at least one module to delegate at least part of a computing task to the server side. WO 2014/043175 PCT/US2013/059160 SUBSTITUTE SHEET (RULE 26)
Patent AU-2019203766-A1 (AU)
Title: System and method for biometric authentication in connection with camera-equipped devices
Inventor: LECUN YANN
IPC: G06V10/764
Filed: 2019-05-29
Abstract: The present invention relates generally to the use of biometric technology for authentication and identification, and more particularly to non-contact based solutions for authenticating and identifying users, via computers, such as mobile devices, to selectively permit or deny access to various resources. In the present invention authentication and/or identification is performed using an image or a set of images of an individual's palm through a process involving the following key steps: (1) detecting the palm area using local classifiers; (2) extracting features from the region(s) of interest; and (3) computing the matching score against user models stored in a database, which can be augmented dynamically through a learning process. 4 *4 A4I' iA Rq~or, o.
Patent AU-2019220404-A1 (AU)
Title: Pyrimidine derivatives for prevention and treatment of bacterial infections
Inventor: LANCELLOTTI PATRIZIO
IPC: C07D487/04
Filed: 2019-02-14
Abstract: New pyrimidine derivatives of formula (I), optionally with a detectable isotope, pharmaceutical composition and method of preparation thereof. New pyrimidine derivatives for use in treatment or prevention of bacterial infection in a host mammal in need of such treatment or prevention and use as inhibitors of biofilm formation on a surface of biomaterial or medical device, particularly of cardiovascular device such as prosthetic heart valve or pacemakers. New pyrimidine derivatives for use as radiotracer in diagnosing or prognosing bacterial infection in a host mammal.
Patent AU-2019235652-A1 (AU)
Title: Bispecific antibodies to MOSPD2 and T cell- or NK cell-specific molecules
Inventor: MENDEL ITZHAK
IPC: C07K14/705
Filed: 2019-03-13
Abstract: Disclosed herein are bispecific antibodies or antigen binding fragments thereof that specifically bind to Motile Sperm Domain Containing Protein 2 (MOSPD2) and to a T cell-specific or NK cell-specific receptor molecule, pharmaceutical compositions and kits containing the same, and methods of making and using the same.
Patent AU-2019250425-A1 (AU)
Title: Vaginal measurements using a vaginal ring
Inventor: DE LAAT WILHELMUS NICOLAAS GERARDUS MARIA
IPC: A61B5/00
Filed: 2019-04-10
Abstract: Method for measuring the presence of a compound or a physiological parameter in the human or animal body, comprising positioning an intravaginal ring that comprises a sensor for the compound or parameter to be measured in contact with the vaginal mucosa and recording a signal produced by the sensor. It is further disclosed a method for the combined administration and measurement of compounds in the human or animal body, comprising the administration of one or more biologically active compounds and the simultaneous and/or subsequent measurement of the presence and/or concentration of the same and/or another compound and/or physiological parameter that is the result of the administration of the one or more biologically active compounds, wherein the measurement is performed with a sensor that is in contact with the vaginal mucosa.
Patent AU-2019255217-A1 (AU)
Title: Methods and apparatus for performing phase operations
Inventor: GIDNEY CRAIG
IPC: G06N10/00
Filed: 2019-04-16
Abstract: Methods, systems, and apparatus for performing phase operations. In one aspect, a method for performing a same phase operation on a first and second qubit using a third qubit prepared in a phased plus state includes: performing a first NOT operation on the third qubit; computing a controlled adder operation on the first, second and third qubit, comprising encoding the result of the controlled adder operation in a fourth qubit; performing a square of the phase operation on the fourth qubit; uncomputing the controlled adder operation on the first, second and third qubit; performing a CNOT operation between the first qubit and the third qubit, wherein the first qubit acts as the control; performing a CNOT operation between the second qubit and the third qubit, wherein the second qubit acts as the control; and performing a second NOT operation on the third qubit.
Patent AU-2019271382-A1 (AU)
Title: Selective androgen receptor degrader (SARD) ligands and methods of use thereof
Inventor: NARAYANAN RAMESH
IPC: A61K31/167
Filed: 2019-05-16
Abstract: This invention is directed to selective androgen receptor degrader (SARD) compounds including heterocyclic rings and pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, triple negative breast cancer, other cancers expressing the androgen receptor, androgenic alopecia or other hyperandrogenic dermal diseases, Kennedys disease, amyotrophic lateral sclerosis (ALS), abdominal aortic aneurysm (AAA), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (AR-FL) including pathogenic or resistance mutations, AR-splice variants (AR-SV), and pathogenic polyglutamine (polyQ) polymorphisms of AR in a subject.
Patent AU-2019277029-A1 (AU)
Title: Binding molecules against BCMA and uses thereof
Inventor: ABUJOUB AIDA
IPC: A61K39/395
Filed: 2019-05-30
Abstract: The present disclosure provides BCMA binding molecules that specifically bind to human BCMA, conjugates comprising the BCMA binding molecules, and pharmaceutical compositions comprising the BCMA binding molecules and the conjugates. The disclosure further provides methods of using the BCMA binding molecules to treat cancers that express cell surface BCMA. The disclosure yet further provides recombinant host cells engineered to express the BCMA binding molecules and methods of producing the BCMA binding molecules by culturing the host cells under conditions in which the BCMA binding molecules are expressed.
Patent AU-2019318120-A1 (AU)
Title: Modified meningococcal fhbp polypeptides
Inventor: SCARSELLI MARIA
IPC: C12N15/62
Filed: 2019-08-09
Abstract: The present invention provides mutated fHbp polypeptides and fusion proteins comprising said mutated fHbp polypeptides that are useful as components of immunogenic compositions for immunizing against
Patent AU-2019322251-A1 (AU)
Title: An improved method for lithium processing
Inventor: BLUNN ADAM
IPC: C25B9/23
Filed: 2019-08-17
Abstract: A method for improved processing of lithium metallurgical solutions comprises the steps of: i. Directing a lithium leach solution containing magnesium to an electrochemical magnesium removal step to form a magnesium depleted lithium leach solution; ii. Directing the magnesium depleted lithium leach solution of step i) to downstream concentration and recovery processes wherein the electrochemical magnesium removal step is a 3 -chamber electrochemical configuration to produce magnesium hydroxide precipitate and a separate hydrochloric acid stream, as recoverable by-products.